Cable Hill Partners’s Novartis NVS Stock Holding History

Cable Hill Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$613K	Sell	5,401 -2,784	-34%	-$296K	0.06%	71
2024 Q4	$796K	Sell	8,185 -3,748	-31%	-$400K	0.08%	58
2024 Q3	$1.37M	Buy	11,933 +550	+5%	+$62.4K	0.14%	34
2024 Q2	$1.21M	Buy	+11,383	New	+$1.14M	0.13%	33
2023 Q4	–	Sell	-10,088	Closed	-$1.03M	–	190
2023 Q3	$1.03M	Buy	10,088 +1,947	+24%	+$198K	0.14%	38
2023 Q2	$822K	Buy	8,141 +731	+10%	+$73.1K	0.11%	45
2023 Q1	$682K	Sell	7,410 -3,403	-31%	-$297K	0.11%	52
2022 Q4	$981K	Buy	10,813 +2,805	+35%	+$236K	0.18%	46
2022 Q3	$609K	Sell	8,008 -316	-4%	-$26.2K	0.12%	59
2022 Q2	$704K	Buy	8,324 +1,424	+21%	+$125K	0.18%	54
2022 Q1	$605K	Buy	6,900 +624	+10%	+$54K	0.4%	40
2021 Q4	$549K	Buy	6,276 +825	+15%	+$68.5K	0.11%	71
2021 Q3	$446K	Buy	5,451 +752	+16%	+$67.7K	0.11%	77
2021 Q2	$429K	Sell	4,699 -255	-5%	-$22.7K	0.1%	76
2021 Q1	$423K	Buy	4,954 +634	+15%	+$56.9K	0.12%	63
2020 Q4	$408K	Sell	4,320 -150	-3%	-$13.1K	0.11%	60
2020 Q3	$389K	Hold	4,470	–	–	0.12%	56
2020 Q2	$390K	Sell	4,470 -305	-6%	-$26.3K	0.13%	47
2020 Q1	$394K	Buy	4,775 +77	+2%	+$6.87K	0.14%	50
2019 Q4	$445K	Sell	4,698 -1,291	-22%	-$116K	0.13%	54
2019 Q3	$520K	Sell	5,989 -707	-11%	-$63.5K	0.17%	43
2019 Q2	$611K	Sell	6,696 -4,407	-40%	-$373K	0.21%	34
2019 Q1	$956K	Sell	11,103 -1,643	-13%	-$132K	0.32%	24
2018 Q4	$980K	Buy	12,746 +12,021	+1,658%	+$936K	0.39%	21
2018 Q3	$56K	Sell	725 -296	-29%	-$21.9K	0.02%	169
2018 Q2	$69K	Buy	1,021 +71	+7%	+$4.9K	0.03%	157
2018 Q1	$68K	Sell	950 -74	-7%	-$5.63K	0.03%	157
2017 Q4	$79K	Sell	1,024 -421	-29%	-$31.8K	0.03%	171
2017 Q3	$112K	Buy	1,445 +1,235	+588%	+$93.3K	0.05%	143
2017 Q2	$15K	Sell	210 -781	-79%	-$55.4K	0.01%	319
2017 Q1	$66K	Buy	991 +879	+785%	+$58.6K	0.03%	120
2016 Q4	$7K	Buy	112 +95	+559%	+$6.16K	﹤0.01%	480
2016 Q3	$1K	Buy	+17	New	+$1.24K	﹤0.01%	823
2016 Q2	–	Sell	-223	Closed	-$15K	–	716
2016 Q1	$15K	Buy	+223	New	+$15.2K	0.01%	284
2015 Q4	–	Sell	-157	Closed	-$13K	–	700
2015 Q3	$13K	Sell	157 -90	-36%	-$8.01K	0.01%	326
2015 Q2	$23K	Hold	247	–	–	0.02%	265
2015 Q1	$22K	Sell	247 -33	-12%	-$2.93K	0.02%	266
2014 Q4	$24K	Buy	+280	New	+$23.2K	0.02%	253

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cable Hill Partners's NVS Position: Q1 2025 in Review

Cable Hill Partners reduced its Novartis (NVS) stake by 34% in Q1 2025, selling an estimated $296K and leaving 5,401 shares worth $613K. The position accounts for 0.06% of the portfolio, ranked #71.

Cable Hill Partners first reported a position in NVS in Q4 2014 and has held it in 38 quarters since. The position peaked at $1.37M in Q3 2024. 1,357 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

Cable Hill Partners held 5,401 shares of Novartis worth $613K as of Q1 2025.
Cable Hill Partners sold 2,784 Novartis shares in Q1 2025, an estimated $296K.
Novartis made up 0.06% of Cable Hill Partners's portfolio in Q1 2025, its #71 holding.
Cable Hill Partners first reported a position in Novartis in Q4 2014 and has held it in 38 quarters since.
Cable Hill Partners's Novartis position peaked at $1.37M in Q3 2024.
1,357 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.